Send me a link:

*Text messaging rates may apply.

 Dow Down1.30% Nasdaq Down1.82%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
53.15 Down 2.39(4.30%) 12:46PM EDT - Nasdaq Real Time Price
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.52-0.56-2.94-2.36
No. of Analysts6.006.004.008.00
Low Estimate-0.62-0.72-5.03-3.27
High Estimate-0.44-0.48-1.79-1.09
Year Ago EPS-0.29-0.48-1.45-2.94
Revenue EstCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate11.07M11.07M40.24M42.10M
No. of Analysts6697
Low Estimate8.38M8.38M33.43M21.90M
High Estimate19.97M19.97M68.18M70.00M
Year Ago Sales8.69M8.99M47.17M40.24M
Sales Growth (year/est)27.40%23.10%-14.70%4.60%
Earnings HistoryJun 13Sep 13Dec 13Mar 14
EPS Est-0.35-0.39-0.45-0.54
EPS Actual-0.29-0.48-0.51-3.70
Difference0.06-0.09-0.06-3.16
Surprise %17.10%-23.10%-13.30%-585.20%
EPS TrendsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.52-0.56-2.94-2.36
7 Days Ago-0.52-0.56-2.94-2.36
30 Days Ago-0.52-0.56-2.94-2.36
60 Days Ago-0.50-0.55-2.02-2.39
90 Days Ago-0.43-0.47-1.89-2.15
EPS RevisionsCurrent Qtr.
Jun 14
Next Qtr.
Sep 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstALNYIndustrySectorS&P 500
Current Qtr.-79.30%N/A-64.20%12.20%
Next Qtr.-16.70%N/A-63.40%20.20%
This Year-102.80%N/A100.60%8.20%
Next Year19.70%N/A44.90%12.30%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)-6.60%21.62%15.47%9.71%
Price/Earnings (avg. for comparison categories)-18.657.106.648.10
PEG Ratio (avg. for comparison categories)2.8328.965.821.84
Currency in USD.